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Biotransformation of organic micropollutants (OMPs) in wastewater treatment plants 
ultimately depends on the enzymatic activities developed in each biological process. 
However, few research efforts have been made to clarify and identify the role of 
enzymes on the removal of OMPs, which is an essential knowledge to determine the 
biotransformation potential of treatment technologies. Therefore, the purpose of the 
present study was to investigate the enzymatic transformation of 35 OMPs under 
anaerobic conditions, which have been even less studied than aerobic systems. Initially, 
13 OMPs were identified to be significantly biotransformed (>20%) by anaerobic sludge 
obtained from a full-scale anaerobic digester, predestining them as potential targets of 
anaerobic enzymes. Native enzymes were extracted from this anaerobic sludge to 
perform transformation assays with the OMPs. In addition, the effect of detergents to 
recover membrane enzymes, as well as the effects of cofactors and inhibitors to promote 
and suppress specific enzymatic activities were evaluated. In total, it was possible to 
recover enzymatic activities towards 10 out of these 13 target OMPs (acetyl-
sulfamethoxazole and its transformation product sulfamethoxazole, acetaminophen, 
atenolol, clarithromycin, citalopram, climbazole, erythromycin, and terbutryn, 
venlafaxine) as well as towards 8 non-target OMPs (diclofenac, iopamidol, acyclovir, 
acesulfame, and 4 different hydroxylated metabolites of carbamazepine). Some 
enzymatic activities likely involved in the anaerobic biotransformation of these OMPs 
were identified. Thereby, this study is a starting point to unravel the still enigmatic 
biotransformation of OMPs in wastewater treatment systems.  
Keywords: anaerobic digestion; degradation; enzymatic transformation; enzymatic 
pathways; pharmaceuticals; sewage treatment plant.  
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1. Introduction 
As all biological processes, also those conducted by microorganisms in sewage 
treatment plants (STPs) depend on the activities of enzymes, which catalyse 
biochemical reactions that otherwise would occur too slowly for keeping organisms 
alive. Enzymes can be selective and extremely efficient catalysts that accelerate the rate 
of specific chemical reactions – such as nucleophilic, electrophilic, and acid-base 
reactions (Broderick, 2001) – by lowering the activation energy without being 
consumed (Frey and Hegeman, 2007). Thus, they do not alter the equilibrium constant 
(final amount of product), but enhance the substrate’s reactivity by their functional 
groups. The protein nature of enzymes allows them to have a dual function as catalysts 
and regulators of metabolic reactions (Bisswanger, 2011). However, most enzymatic 
reactions need cofactors, which are either organic molecules (coenzymes) with 
functional groups not present in proteins or metal ions required for catalysis and stability 
of the enzyme (Frey and Hegeman, 2007). Coenzymes are, for example, essential in 
electrophilic and redox reactions, rearrangements, or group transfers (Broderick, 2001). 
Biological treatment processes possess the capacity to transform many organic 
micropollutants (OMPs), such as pharmaceuticals, biocides and personal care products, 
as well as their transformation products (TPs). Yet, to maximize their efficiency, the 
underlying biotransformation mechanisms and the influencing factors need to be 
understood. Several authors suggested that cometabolism is likely the major mechanism 
responsible for OMP biotransformation in STPs as the concentrations of OMPs are too 
low to become a growth substrate (Delgadillo-Mirquez et al., 2011; Fernandez-Fontaina 
et al., 2016; Fischer and Majewsky, 2014; Plósz et al., 2010; Pomiès et al., 2013). This 
process is enabled by the low specificity of certain enzymes and cofactors (Criddle, 
1993; Horvath, 1972). The study of any metabolic or cometabolic pathway requires a 
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comprehensive understanding of the enzymes involved. Nevertheless, there is a 
surprisingly huge gap between the importance and the research efforts made to elucidate 
the responsible enzymes for OMP biotransformation as was already stated by Fischer 
and Majewsky (2014). This could be due to the extremely high complexity of biological 
systems in STPs and to the lack of information about the involved enzymes. Actually, 
thousands of enzymes exist, but less than 15% are described in detail, and only hundreds 
are commercially available (Bisswanger, 2011).  
To date, most studies have focused on activated sludge enzymes, particularly on 
oxidoreductases (Fernandez-Fontaina et al., 2016; Kassotaki et al., 2016; Men et al., 
2017). However, recent advances have been made on exploring the role of other 
enzymatic activities such as hydrolases (Krah et al., 2016), enzymes acting on OMPs 
with amine groups (Gulde et al., 2016), and enzymes involved in bisphenol A 
degradation (Zhou et al., 2015). Certain enzymes can be found in both aerobic and 
anaerobic STP systems, such as hydrolases (Goel et al., 1998) and transferases (e.g., 
hexokinase) (BRENDA The Comprehensive Enzyme Information System) whose 
activity do not depend on redox conditions and are involved in several metabolic 
pathways; thus, some links between aerobic and anaerobic biotransformation of OMPs 
could be found. Nevertheless, specific enzymes of each process can be responsible for 
the reported biotransformation differences (Alvarino et al., 2014; Falås et al., 2016). 
Yet, to the best of our knowledge, only one study (Gonzalez-Gil et al., 2017) so far 
investigated the OMP biotransformation by enzymes present in microorganisms favored 
under anaerobic conditions (namely by acetate kinase).  
Anaerobic systems, such as upflow anaerobic sludge blanket (UASB) and anaerobic 
digestion (AD), are widely used in STPs in both water and sludge lines, and thus might 
be key in the removal of OMPs. Falås et al. (2016) have pointed out that the removal of 
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OMPs can be enhanced by combining different aerobic and anaerobic treatments, 
leading to a substantial improvement in detoxification (Völker et al., 2017).  
This study pursued to broaden the knowledge about the enzymatic transformation of 
OMPs under anaerobic conditions in order to understand and explore the (co)metabolic 
limits of anaerobic microbial communities in the removal of OMPs. Firstly, we aimed 
to prove the key role of enzymes in the anaerobic biotransformation of 35 OMPs through 
experiments with enzymes directly extracted from anaerobic sludge. Furthermore, we 
intended to go a step forward in identifying possible enzymatic activities involved in 
OMP biotransformation by combining the knowledge about OMP reactivities and 
enzymatic processes, specifically by employing detergents, cofactors and inhibitors.  
2. Materials and Methods 
2.1 Organic micropollutants (OMPs) 
35 OMPs were measured: 10,11-Dihydro-10,11-dihydroxycarbamazepine (10,11-
DiOH-CBZ), 10,11-Dihydro-10-hydroxycarbamazepine (10-OH-CBZ), 2-
hydroxycarbamazepine (2-OH-CBZ), 3-hydroxycarbamazepine (3-OH-CBZ), 
acesulfame, acetaminophen, N-acetyl-sulfamethoxazole (acetyl-SMX), acyclovir, 
atenolol, benzotriazole, bezafibrate, carbendazim, carbamazepine (CBZ), citalopram, 
clarithromycin, climbazole, codeine, diatrizoate, diclofenac, diuron, erythromycin, 
fluconazole, iopromide, iopamidol, iomeprol, isoproturon, mecoprop, metoprolol, 
oxazepam, primidone, sotalol, terbutryn, tramadol, trimethoprim, and venlafaxine. As 
well, 14 transformation products (TPs) of acetyl-SMX (SMX), acyclovir (carboxy-
acyclovir), carbamazepine (9-carboxy-acridine and acridone), climbazole (climbazole-
alcohol), trimethoprim (4-desmethyltrimethoprim), citalopram (N-
desmethylcitalopram), terbutryn (terbutryn-sulfoxide), venlafaxine (N-
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desmethylvenlafaxine, O-desmethylvenlafaxine and N,O-didesmethylvenlafaxine) and 
tramadol (N-desmethyltramadol, O-desmethyltramadol and N,O-didesmethyltramadol) 
were monitored. These compounds were selected to cover a broad spectrum of 
commonly occurring micropollutants in STPs, with different physicochemical 
characteristics (Table S1) and biotransformation rates (Falås et al., 2016). The chemical 
structures of OMPs are provided in Table S2. To minimize removal by volatilization or 
sorption non-volatile and hydrophilic OMPs were chosen. These hydrophilic 
compounds are either present in the water and sludge lines of STP, since sewage sludge 
mainly consists of water (> 95%) (Gonzalez-Gil et al., 2016; Verlicchi and Zambello, 
2015).  
2.2 Anaerobic sludge 
Anaerobic sludge samples were collected from a full-scale anaerobic digester operating 
at a German STP (Koblenz-Wallersheim, 320,000 population equivalents and 61,000 
m3/d average flow rate). The characteristics of the anaerobic sludge were almost stable 
along all sampling campaigns (n=5). The average pH was 7.5 ± 0.3 and the average 
concentrations of total (TSS) and volatile (VSS) suspended solids were 22.1 ± 0.7 g/L 
and 12.3 ± 0.4 g/L, respectively. Sludge was stored at 4 °C and handled on ice after 
sampling to preserve the enzymatic activities. 
2.3 Basic procedure to extract enzymes  
Extraction of proteins from sludge was performed as previously described (Krah et al. 
2016) following a procedure similar to proteomic analyses (Barr et al., 2016), although 
it cannot be excluded that some extracellular enzymes might be lost. Briefly, sludge was 
centrifuged for 6 min at 3,500 g, and the sludge pellets were washed and resuspended 
with HN-buffer (50 mM HEPES, 50 mM NaCl, pH 7.4 adjusted with NaOH) to obtain 
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a more concentrated cell suspension (31.9 ± 2.2 g TSS/L and 17.6 ± 0.6 g VSS/L). 
Sludge samples were homogenized and microbial cells were disrupted by 
ultrasonication on ice with a power density of 1 W/mL for 10 min (15 s intervals). Cell 
debris was removed by centrifugation at 4 ºC for 20 min at 14,000 rpm and the 
supernatant was filtered over 0.2 µm to avoid the removal of OMPs by sorption. The 
resulting cell-free lysate (termed as basic lysate) was kept on ice until its 
characterization and usage in enzymatic transformation assays or frozen in liquid N2 and 
stored at −80 °C in case the assays were not performed on the same day.  
2.4 Modifications of the extraction procedure  
Some variations with respect to the basic extraction procedure (i.e., lysis method, buffer 
and addition of detergents) to obtain different cell-free lysates were conducted. Bead 
beating was evaluated as an alternative to disrupt cells instead of ultrasounds. It was 
performed in 15 mL tubes filled with lysing matrix E (MP Biomedicals) for different 
times: 40 s, 80 s, 120 s and 160 s (in 20 s intervals at 6 m/s, with 5 min pauses for 
cooling). The use of phosphate buffer (50 mM KH2PO4, 50 mM NaCl, pH 7.4) instead 
of HN-buffer was tested using sonication and bead beating (160 s).  
Detergents are essential additives to solubilize membrane proteins. However, there are 
no detergents suitable for all membrane proteins (Linke, 2009); thus, three detergents 
were individually added to the HN-buffer: octylthioglucoside (20 mM), β-
dodecylmaltoside (5 mM) and CHAPS (10 mM). The two first ones are nonionic 
detergents, while the third is zwitterionic. Concentrations are above the critical 
micellization concentration to allow solubilisation of all membrane proteins and for 
keeping them in solution by micelles (Linke, 2009). The lysis method used with 
detergents was bead beating (80 s) to avoid excess foam formation.  
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2.5 Characterization of lysates: protein concentration and enzymatic activities 
Lysates were characterized in terms of protein concentration and three enzymatic 
activities (phosphatase, β-galactosidase and acetate kinase). The selection of these 
enzymes was based on their different microbial origin, catalytic action and location 
(intracellular/extracellular) (BRENDA The Comprehensive Enzyme Information 
System). Protein concentrations were measured in triplicate using the bicinchoninic acid 
(BCA) method with a BCA protein quantitation kit (Interchim Uptima). Phosphatase 
and -galactosidase activities were measured in quadruplicates by using p-nitrophenyl 
phosphate and p-nitrophenyl β-D-galactopyranoside as substrates, following the 
procedure described in Krah et al. (2016). One unit (U) of enzyme activity releases 1 
μmol of the corresponding substrate per min at 37 °C. Acetate kinase activity was 
measured in triplicate adapting the procedure reported by Gonzalez-Gil et al. (2017) to 
96-well plates and using a standard curve generated with known amounts of acetyl 
phosphate. In this case, 1 U of enzyme phosphorylates 1.0 μmol of acetate (substrate) 
to acetyl phosphate per minute at pH 7.6 and 25 °C. All enzymatic activities were 
corrected by subtracting the value obtained from the respective heat-deactivated lysates 
(15 min at 99 °C). Results are shown in Supplementary Data Section II. 
2.6 OMP transformation assays 
The design of the transformation assays was adapted from Krah et al. (2016) to be 
performed in an anaerobic atmosphere. Lysates were placed on ice inside an anaerobic 
chamber under an argon atmosphere. 20 µL OMP mix (0.1 ng/µL per compound 
dissolved in water) were added to 100 µL of lysate in sealed screw cap tubes preserving 
anaerobic conditions. The resulting spike concentration was 16.7 µg/L per OMP. 
Positive controls with intact anaerobic sludge in HN-buffer and negative controls with 
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the corresponding heat-deactivated (15 min at 99 °C) lysate/sludge were conducted. 
Reaction tubes were incubated in a climate chamber at 30 °C for 72 h. Samples were 
taken after 15 min, 6 h, 24 h, 48 h and 72 h. All experiments were performed in triplicate 
(n=3) except for the negative controls (n=1). Reactions were stopped at the specified 
time points by simultaneous heat deactivation. Positive controls were centrifuged for 
7 min at 2,500 g to collect a solid-free supernatant prior OMP analysis. 
In total, four transformation assays in triplicate (n=12) were conducted with the basic 
lysate and two transformation assays in triplicate (n=6) with anaerobic sludge (positive 
control). In these repeated experiments, different daily fresh sludges from the STP were 
used to obtain new basic lysates or to directly use them in the positive controls.  
2.7 Addition of cofactors and inhibitors 
Cofactors could be lost during the extraction process and limit enzymatic activities. 
Therefore, some common cofactors in biological reactions (Zhao and Van Der Donk, 
2003), which are commercially available, were supplied in the OMP transformation 
assays. The selected cofactors were: NAD+ (40 mM), NADH (20 mM), and NADP 
(40 mM), which are nicotinamide coenzymes playing a key role in oxidation and 
reduction reactions; the nucleoside triphosphate ATP (30 mM), which provides energy 
and a phosphate group for phosphorylations in the presence of Mg2+ (30 mM) as 
counterion in ATP-dependent reactions (Bisswanger, 2014); and coenzyme A (CoA, 
3 mM) needed for acyl group transfer and carboxylate activation, key reactions in fatty 
acids biosynthesis (Broderick, 2001). Catalytic reactions with CoA such as acetate and 
acetyl-CoA production by bacteria or archaea (Ferry, 2015) usually require energy. 
Hence, Mg2+ (30 mM) and ATP (30 mM) were simultaneously provided. The cofactors 
were added at theoretical saturating concentrations, 10-times their Km (Michaelis half 
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saturation constant) (Bisswanger, 2014). Km values vary for each enzyme, so the 
minimum value enclosing 95% of non-recombinant or mutant proteins (BRENDA The 
Comprehensive Enzyme Information System) was employed. 
Inhibitors of several enzymatic classes were individually added to the basic lysate to 
confirm authors’ hypotheses about possible anaerobic transformations of OMPs. 
Peptidase inhibitors as E-64 (5 µM) for cysteine peptidases, Pefabloc® SC (AEBSF, 
1 mM) for many serine peptidases and pepstatin A (1 µM) for aspartic peptidases (Krah 
et al., 2016); castanospermine (1 mM) as glycosidase inhibitor (Junge et al., 1996); and 
2-bromoethanesulfonate (BES, 50 mM) as methanogenic inhibitor (Liu et al., 2011).  
OMP transformation assays with cofactors or inhibitors were performed in triplicate 
(n=3) plus a negative control per time-point. They were added before the OMP spike, 
and in the case of negative controls after its heat-deactivation. 
2.8 Analysis of OMPs 
In order to reduce the number of samples to be measured, triplicates were only analysed 
separately at the beginning (time 15 min) and at the end of the experiment (72 h). 
Triplicate samples of each mid time point (6 h, 24 h and 48 h) were pooled and measured 
as composite samples. In sum, 9 samples were analysed per assay plus the negative 
controls at the time points 15 min and 72 h.  
Prior to analysis, samples were diluted (1:40) with ultrapure water and spiked with a 
labelled surrogate mix to attain a final concentration of 0.83 µg/L of OMPs and 0.2 µg/L 
of surrogate mix. A sample aliquot of 80 µL was then injected in a reversed-phase liquid 
chromatograph (Agilent 1260 Series, Agilent Technologies) coupled to an electrospray 
mass spectrometer (LC-ESI-MS/MS; AB SCIEX TripleQuad™ 5500 mass 
spectrometer, Applied Biosystems). Chromatographic separation was performed on a 
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Zorbax Eclipse XDB-C18 column (2.1 x 150 mm, 3.5 µm). An internal standard 
calibration was used for quantification. All target compounds were measured within one 
chromatographic run by scheduled multiple reaction monitoring (sMRM) using 
electrospray ionization (ESI) in both negative and positive mode. At least two mass 
transitions were measured for quantification and confirmation. Further details on the 
methodology are described by Falås et al. (2016). To minimize experimental deviations 
affecting the final concentration of OMPs, they were normalized by the concentration 
of fluconazole, which is a persistent (Kahle et al., 2008; Krah et al., 2016) and polar 
compound and was not transformed in any assay. For identification of potential TPs 
selected samples were additionally analysed by high-resolution LC–QToF-MS (HPLC, 
Agilent 1260 series; MS, Sciex 5600 TripleTOF) according to a method described in 
Jewell et al. (2016). Three identification criteria had to be fulfilled to support the 
proposed structures of TPs. These were the exact mass (± 10 mDa), the isotopic pattern, 
and the presence of at least two fragments in the MS2 spectrum which can be explained 
by the molecular structure of the respective TP. Additionally, it was verified that these 
TPs were not formed in the negative controls. 
2.9 Statistical analysis 
Three criteria were established to consider OMP biotransformation significant in the 
positive controls with anaerobic sludge (n=2, in triplicate) and in the basic lysate (n=4, 
in triplicate): 1) removal efficiency ≥ 20%, 2) significant differences between OMP final 
and initial concentrations (C0), and 3) significant differences between OMP final and 
negative control concentrations. Negative control concentrations were calculated as the 
average value from 2 (positive control) or 4 (basic lysate) experiments.  
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To evaluate the effect of different extraction conditions, cofactors and inhibitors on 
OMP biotransformation, the respective removal difference to the basic lysate was 
calculated. This ∆Removal value was considered significant when: 1) ∆Removal ≥ 25 
percentage points (pp) and 2) the final C/C0 values (n=3) were significantly different. 
As indicated in the Result and Discussion section, some OMPs seem to undergo a 
reversible transformation and thus showed a maximum removal after 6‒48 h. Since 
these values correspond to composite samples (n=1), no statistical analysis was 
performed and only criteria 1) was applied. 
The general threshold of 20% for significant removal and of 25 percentage points (pp) 
for significant removal differences (∆Removal) were set as realistic values (e.g. Falås 
et al., 2016; Rühmland et al., 2015) taking analytical uncertainties and error propagation 
into account. For values above the thresholds, significant differences were calculated by 
the Student’s t-test. The variance homogeneity of data was determined applying the 
Levene’s test. All of the statistical tests were performed at a 5% significance level using 
the IBM SPSS statistics® software 22.0. Error bars of C/C0 ratios were calculated 
through Gaussian error propagation considering standard deviations of both the final 
(n=3) and initial (n=3) concentrations. 
3. Results and Discussion 
3.1 Removal of OMPs in anaerobic sludge vs. basic lysate 
An initial screening for target OMPs that might undergo an enzymatic transformation 
under anaerobic conditions was conducted through evaluating the removal of 35 spiked 
OMPs in anaerobic sludge (positive controls). The removal efficiencies shown in Figure 
1 reveal that the concentrations of 22 OMPs were decreased after 72 h to different 
extents. Relative removal efficiencies over time are shown in Figure S4 for some 
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compounds as an example. Among the 22 OMPs, a relevant removal (> 20%) in the 
anaerobic sludge was only observed for 15 OMPs including the antibiotic SMX. This 
compound was not spiked but formed from the human metabolite acetyl-SMX and then 
further transformed by the anaerobic sludge (Figure S4a). Most of these results are 
consistent with literature (Falås et al., 2016; Gonzalez-Gil et al., 2016; Narumiya et al., 
2013; Völker et al., 2017). However, Völker et al. (2017) reported higher removal 
efficiencies for tramadol and codeine and Falås et al. (2016) for diatrizoate, while 
terbutryn was not removed in that study at all. For these 15 compounds, the 
concentrations after the incubation time were statistically different (p ≤ 0.05) from the 
initial concentration and, except for iomeprol and iopromide, significantly different 
(p ≤ 0.05) from the heat-deactivated negative controls. Therefore, only 13 OMPs 
underwent a significant biotransformation. Some of these compounds (e.g., 
clarithromycin (Figure S4b), erythromycin, citalopram, climbazole, and terbutryn, data 
not shown) seem to undergo a reversible biotransformation, since their concentration 
increased again after 6‒48 h.  
Despite tramadol removal being below the established threshold limit (20%) the 
formation of O-desmethyltramadol and N,O-didesmethyltramadol in sludge (Figure 
S4c) indicates that this OMP was anaerobically biotransformed. The demethylation of 
methoxy groups has been described as a rather common anaerobic transformation 
reaction of micropollutants (Ghattas et al., 2017). Consistently, also the O-
demethylation of trimethoprim was confirmed by the observed formation of 4-
desmethyltrimethoprim (Figure S4d). As predicted by Jewell et al. (2016) this TP is not 
stable and is further transformed. However, the O-demethylation of venlafaxine as 
observed by Falås et al. (2016) could not be detected (Figure S4f).  
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Figure 1. Average OMP removal efficiencies in anaerobic sludge (positive controls; 
n=2, in triplicate) and in basic lysates (n=4, in triplicate). Average removal values were 
calculated after 72 h of reaction, except for clarithromycin, erythromycin, citalopram, 
climbazole and terbutryn (6‒48 h, depending on the compound). Error bars represent 
maximum and minimum values of two experiments (n=2) for anaerobic sludge and 
standard deviation (n=4) for basic lysate. Vertical lines classify compounds according 
to their removal efficiencies: high (>75%), medium-high (50‒75%), medium-low (20‒
50%), persistent (< 20%, not significant).  
After identifying the OMPs significantly removed by anaerobic sludge (positive 
control), we would have expected that the extracted enzymes in the basic lysate could 
exert some significant activity towards these 13 OMPs. However, only 8 compounds 
(acetyl-SMX, acetaminophen, clarithromycin, erythromycin, citalopram, climbazole, 
atenolol and terbutryn) were substantially transformed by the lysate, while the removal 
of SMX and venlafaxine was below the uncertainty threshold of 20% (Figure 1). For 
these 8 compounds the minimum concentrations in the basic lysates were statistically 
different (p ≤ 0.05) from the initial concentrations and from the negative controls. As 
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transformation pattern in the lysate (e.g. Figure S6e-g). Surprisingly, trimethoprim, 
which was highly biotransformed under anaerobic conditions in the positive controls, 
remained unaltered by the enzymes present in the basic lysate. Except for 
acetaminophen, the removal of OMPs in the basic lysate was below the value obtained 
in the anaerobic sludge. This lower biotransformation removal of OMPs in the basic 
lysate was expected because it is a high challenge to mimic in vitro the optimal 
enzymatic conditions present in an intact cell. In addition, these differences might be 
caused by an incomplete recovery of the sludge enzymes using the basic extraction 
procedure and/or a lower enzymatic activity in the lysate due to missing co-factors or 
the suppression of certain metabolic pathways active in intact cells.   
Sorption is disregarded as a removal mechanism in the experiments with sludge and 
particularly in the lysates (filtered over 0.2 µm) due to the hydrophilic nature of the 
spiked OMPs, which mostly have low octanol-water coefficients (Kow, Table S1) and 
partitioning coefficients (Kd) below 500 L/kg (Falås et al., 2016). Moreover, the final 
concentrations of OMPs are significantly different (p ≤ 0.05) from the heat-deactivated 
negative controls, therefore, the removal efficiencies shown in Figure 1 can be mainly 
attributed to biological (enzymatic) transformations of the OMPs. 
3.2 Influence of extraction conditions on the enzymatic transformation of OMPs 
Several modifications to the basic extraction procedure (ultrasonication in HEPES-
based HN-buffer) were performed in order to broaden the specificity and increase the 
enzymatic activities recovered in the lysate. The effects on protein concentration (Figure 
S1), galactosidase (Figure S2), phosphatase (Figure S2) and acetate kinase activities 
(Figure S3) are discussed in Section II of the Supplementary Data. Since the whole 
variety of enzymes and their activities in each lysate is unknown, almost all extraction 
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modifications (6 out of 9) were evaluated with OMPs: bead beating for 80 s and 160 s, 
phosphate buffer + bead beating for 160 s, and the individual addition of three detergents 
to the HN-buffer prior bead beating for 80 s. All these enzymatic lysates were extracted 
from the same anaerobic sludge sample and were compared to the corresponding basic 
lysate. The removal differences (∆Removal) with respect to the basic lysate are shown 
in the heat-map of Table 1. Further information is reported in Table S3. A molecular 
mass balance was established for the consumed acetyl-SMX and the production of SMX 
to calculate the overall removal of SMX. 
Table 1. Removal of selected OMPs in the enzymatic lysates obtained with different 
extraction methods compared to the basic lysate (∆Removal, pp) after 72 h. Only the 11 
OMPs that can be potentially transformed in the basic lysates (Figure 1) plus the OMPs 
significantly removed under the new conditions (below the dashed line) were included. 
Only absolute values ≥ 10 pp are shown. The absolute values in bold are statistically 
significant (p ≤ 0.05 and ∆Removal ≥ 25 pp). Detergents M, T and C stand for 
dodecylmaltoside, octylthioglucoside and CHAPS, respectively.  
 Bead Beating  Detergents 
 
 80 s 160 s 160 s (PO4) M T C  
Acetaminophen1      -37 -34 
Acetyl-SMX -21  -30 -21 -50 -49 
SMX    54 -26 49 
Atenolol    -15 -34 -24 
Citalopram2    -13 -19 -25 
Clarithromycin2    -24 -34 -22 
Climbazole   -11  49  
Diclofenac      -10 
Erythromycin2    -24 -24 -17 
Terbutryn     43  
Venlafaxine       
Acyclovir 36 71  34 15 15 
1 Completely removed in all the cases. ∆Removal after 6 h of reaction are depicted to appreciate differences on the 
transformation rate.  


















































3.2.1 Lysing method and extraction buffer 
The lysing method, sonication (basic lysate) vs. bead beating (for 80 and 160 s), as well 
as the extraction buffer, HEPES vs. phosphate (bead beating for 160 s), had a low impact 
on the recovered enzymatic activities towards OMPs (Table 1), despite leading to 
different protein concentration (Figure S1). This indicates that the responsible enzymes 
were extracted with all lysing methods. Only for acetyl-SMX and acyclovir the 
differences were relevant (>25 pp). In the case of acetyl-SMX, the use of phosphate 
buffer has a negative impact on its transformation into SMX. Despite acyclovir being 
not considerably removed (< 20%) by anaerobic sludge (Figure 1), the lysate obtained 
through bead beating (160 s) was able to transform it (p ≤ 0.05) only when HEPES 
buffer was used (Table 1); thus, phosphate buffer seemed to have a negative effect. It 
should be noted that the decrease in the concentration of acyclovir occurred only in the 
last time-point (Figure S5a) of the assay concomitantly with the formation of carboxy-
acyclovir by oxidation of the primary hydroxyl group of acyclovir (Figure S5b), as 
reported by Prasse et al. (2011) in activated sludge. This fact suggests that the 
responsible enzymatic activities could be initially hindered.  
In summary, as the different lysing methods and extraction buffers showed a minor 
effect on the transformation of most OMPs, sonication in HEPES buffer was kept as 
lysis method to examine the effect of inhibitors and cofactors on OMP 
biotransformation. 
3.2.2 Use of detergents for extracting membrane enzymes 
Three detergents (octylthioglucoside, dodecylmaltoside and CHAPS) were added to the 
HN-buffer prior to enzyme extraction by bead beating (80 s). The objective was to 
favour the solubilisation of membrane proteins in order to investigate their putative role 
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on OMP biotransformation. Surprisingly, detergents showed a negative effect on the 
enzymatic transformation of several OMPs (Table 1), which could be due to a decrease 
of enzyme activities (Mogensen et al., 2005). Only in the case of SMX, climbazole and 
terbutryn a significant increase in the biotransformation efficiency (>25 pp and p ≤ 0.05) 
was observed with at least one detergent (Table 1, Figure 2). Therefore, some specific 
membrane proteins could be involved in the biotransformation of these OMPs, as it is 
further discussed in section 3.5. The effect of the tested detergents is diverse because 
they are likely not suitable for solubilizing the same membrane proteins (Linke, 2009). 
Based on all these results, the use of detergents and their selection would depend on the 
final purpose of the enzymatic lysate and the target OMPs. Due to their negative impact 
on the transformation of several OMPs, its use is only recommended when membrane 
proteins are involved.  
 
Figure 2. Effect of selected extraction conditions on the biotransformation of three 



























































(transformation product of acetyl-SMX). Names in legends refer to basic lysate 
(obtained by sonication), to bead beating for 80 s (BB80), and to the added detergents 
dodecylmaltoside (M), octylthioglucoside (T) or CHAPS (C). Each time point 
represents the molar concentration ratio (C/C0) (average of triplicates for the first and 
last time point and single values of composite samples for the second, third and fourth 
time point). Error bars (first and last time point) depict the standard deviation calculated 
using Gaussian error propagation.  
3.3 Influence of cofactors on the enzymatic transformation of OMPs 
Five coenzymes were individually added to the basic lysate, in order to encourage 
catalytic activities that might have been inactivated during the lysis procedure. For some 
OMPs, the addition of cofactors had positive effects on their enzymatic transformation 
(Table 2). Surprisingly, 10-OH-CBZ (Figure 3d) and also the other hydroxy-
carbamazepines (10,11-DiOH-CBZ, 2-OH-CBZ and 3-OH-CBZ, Figure S6i-k), which 
were not biotransformed by anaerobic sludge and neither by the basic lysate, were highly 
transformed (> 60% in all cases) in the lysates supplemented with NADH. Although 
NADH did not have an effect on the removal efficiency of climbazole (Figure S6g), 
formation of its reduced TP (climbazole-alcohol) was only detected in the presence of 
NADH (Figure S6h). This suggests that different enzymes can be involved in the 
biotransformation of climbazole. Additionally, the coenzymes NAD+ and/or NADP+ 
clearly favoured the enzymatic transformation of iopamidol (Figure 3b), acesulfame 
(Figure 3c) and acyclovir (Figure S6d), although no significant increase of carboxy-
acyclovir formation was observed. The removal efficiencies achieved (Table S4) were 
even above the maximum values obtained with anaerobic sludge (Figure 1), probably 
because the addition of these oxidizing cofactors modified the reducing conditions that 
prevail in anaerobic systems, and thus thermodynamically not favoured anaerobic 
biotransformation pathways were promoted. Actually, acesulfame and acyclovir are 
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reported to be highly biotransformed in aerobic and anoxic conditions but not in 
anaerobic systems (Castronovo et al., 2017; Falås et al., 2016). 
Table 2. Removal change of OMPs upon addition of cofactors to the basic lysate 
(∆Removal, pp) in a 72 h assay. Only the 11 OMPs that can be potentially transformed 
in the basic lysates (Figure 1) plus the OMPs removed under the new conditions (below 
the dashed line) were included. Only absolute values ≥ 10 pp are shown. The absolute 
values in bold are statistically significant (p ≤ 0.05 and ∆Removal ≥ 25 pp). 
  NADH NAD+ NADP+ ATP ATP+CoA  
Acetaminophen1  -24 -43 -96 -96 
 
Acetyl-SMX -25 -66 -58 -83 -83 
SMX -12 -13 18 -14 -14 
Atenolol  -40 -40 -40 -40 
Citalopram2  -37 -21 -37 -37 
Clarithromycin2  -16   -34 
Climbazole2  -27 —  -16 
Diclofenac -14 10    
Erythromycin2  -15  -17 -11 
Venlafaxine  -14 -14 -14 -14 
Acesulfame  36     
Acyclovir   32   
 
Bezafibrate 15     
 
Iopamidol  26 35   
 
10-OH-CBZ 70     
 
Terbutryn data was not available. 
1 Completely removed in the basic lysate and when NADH, NAD+ or NADP+ was added. In these cases, ∆Removal 
was calculated after 6 h.  
2 ∆Removal after 6 and 24 h (maximum removal), then removal decreases due to reversibility of reactions.  
However, in most cases the addition of cofactors showed negative effects on compound 
removals (Table 2). For instance, ATP completely inhibited the enzymatic 
transformation of acetaminophen (Figure 3a), acetyl-SMX (Figure S6a), atenolol 
(Figure S6c) and citalopram (Figure S6e). A possible explanation could be that ATP 
might act as an end-product inhibitor (allosteric regulation) as was shown for several 
enzymes involved in cellular respiration (Frey and Hegeman, 2007). Accordingly, it 
could be speculated that these four OMPs might be targets of enzymes depending 

















































efficiently biotransformed upon addition of oxidizing cofactors (NAD+ or NADP+) 
(Table 2 and Figure S6). These cofactors could hinder the electron supply needed in 
cellular ATP production (Ishii et al., 2012), supporting the suggested hypothesis. In 
contrast, when NADH (source of electrons) was provided, only the transformation of 
acetyl-SMX was significantly inhibited (∆Removal = -25 pp).  
It should be pointed out, that the supply of cofactors despite providing interesting 
information about the underlying possible enzymatic pathways of OMP transformation, 
might lead to reactions that otherwise will not occur in anaerobic reactors. Therefore, a 
careful discussion of underlying possible enzymatic pathways is conducted in section 
3.5.
 
Figure 3. Significant effects of cofactors on the biotransformation of four spiked OMPs 
(16.7 µg/L). Names in legends refer to basic lysate plus the corresponding cofactor 



























































triplicates for the first and last time point and single values of composite samples for the 
second, third and fourth time point). Error bars (first and last time point) depict the 
standard deviation calculated using Gaussian error propagation.  
3.4 Influence of inhibitors on the enzymatic transformation of OMPs 
Table 3 summarizes the effect on the biotransformation of OMPs when specific 
inhibitors were added to the basic lysate. Further details about the removal efficiencies 
achieved in each case are specified in Table S5. The enzymatic transformation of 
clarithromycin (Figure 4d), climbazole (Figure S7b), citalopram (Figure S7c), and 
erythromycin (Figure S7d) was impaired by the three supplemented peptidase inhibitors, 
although significant differences (∆Removal ≤ -25 pp, p ≤ 0.05) were only found with E-
64 and AEBSF (Table 3). Atenolol transformation was completely inhibited by AEBSF 
(Figure 4c), but not by pepstatin A or E-64 (Table 3), suggesting that serine peptidases 
might entirely be responsible for its biotransformation. 
Erythromycin and clarithromycin are candidate target compounds of glycosylase 
enzymes as their chemical structures include the hexose sugar cladinose (Table S2). 
However, the effect of the glycosylase inhibitor castanospermine on these antibiotics 
and on the remaining OMPs was negligible (Table 3). This fact does not imply that 
glycosylases are not at all involved in the biotransformation of erythromycin, 
clarithromycin or other compounds, as castanospermine only inhibits specific 
glucosidases, such as α- and β-glucosidases (Junge et al., 1996), among more than 200 
described glycosylases (Swiss Institute of Bioinformatics). Surprisingly, this inhibitor 
seems to have a slight (∆Removal <25 pp) but significant (p ≤ 0.05) positive effect on 
the enzymatic transformation of the contrast media iomeprol, iopamidol and iopromide 
(Figure S7a, Table 3), which were not significantly removed in the basic lysate. This 
might indicate an involvement of glycosylated enzymes in these biotransformation 
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reactions as the addition of castonospermine could increase their amount (Skropeta, 
2009). 
BES is widely regarded as a methanogen-specific inhibitor, particularly of methyl-CoM 
reductase, because it is structurally analogue to Coenzyme M (CoM), a cofactor found 
in all methanogens (Liu et al., 2011). Acetyl-SMX transformation to SMX was the only 
reaction significantly inhibited by the addition of BES (Table 3 and Figure 4a,b). 
Nevertheless, the direct involvement of methyl-CoM reductase in this reaction is very 
unlikely, and thus the effect of BES cannot be explained, maybe because this inhibitor 
is not as specific as expected (Xu et al., 2010).  
Table 3. Removal change of OMPs upon addition of inhibitors to the basic lysate 
(∆Removal, pp) in a 72 h assay. Only the 11 OMPs that can be potentially transformed 
in the basic lysates (Figure 1) plus the OMPs removed under the new conditions (below 
the dashed line) were included. Only absolute values ≥ 10 pp are shown. The absolute 
values in bold are statistically significant (p ≤ 0.05 and ∆Removal ≥ 25 pp). 
   Peptidase  Glycosidase Methanog.  
  Pepstatin A E-64 AEBSF Castanosp. BES  
Acetaminophen1      
 
Acetyl-SMX     -26 
SMX    11  
Atenolol   -27   
Citalopram2 -14 -17 -25   
Clarithromycin2 -21 -27 -27  -16 
Climbazole2 -18 -26 -21 -15 -13 
Diclofenac      
Erythromycin2  -20 -27  -10 
Terbutryn2  -12  —  
Venlafaxine      
Iomeprol    17  
 
Iopamidol    15  
Iopromide    17  
1 Completely removed in all the cases. Therefore, ∆Removal after 6 h of reaction are depicted to appreciate 
differences on the transformation rate. 

















































Overall, the use of inhibitors is an appropriate approach when they are very enzyme-
specific, and thus a decrease in the OMP transformation can be directly linked with the 
inhibited enzyme. Besides specificity, the selection of the inhibitors should be made 
based on previous hypotheses about transformation reactions that want to be confirmed. 
 
Figure 4. Significant effects of inhibitors on the biotransformation of three spiked 
OMPs (acetyl-SMX, atenolol and clarithromycin, 16.7 µg/L) and SMX (transformation 
product of acetyl-SMX). Names in legends refer to basic lysate plus the corresponding 
inhibitor: 2-bromoethanesulfonate (BES), serine peptidase inhibitor (AEBSF) and 
cysteine peptidase inhibitor (E-64). Each time point represents the molar concentration 
ratio (C/C0) (average of triplicates for the first and last time point and single values of 
composite samples for the second, third and fourth time point). Error bars (first and last 




























































3.5 Potential enzymes involved in OMP biotransformation 
The use of detergents, cofactors and inhibitors triggered or suppressed the 
transformation of several OMPs, providing interesting information about the involved 
enzymatic activities under anaerobic conditions. In this section, we discuss the 
assembled results with bibliographic data, taking into account the chemical structures 
of OMPs (Table S2) as well as the formed TPs, to develop some grounded hypotheses 
on the responsible enzymes catalysing OMP biotransformation, as summarized in Table 
4. Besides, it should be highlighted that apart from the enzymatic mechanisms of OMP 
transformation proposed in this section, also other enzymes not mentioned are certainly 
involved. 
Acetyl-SMX was highly transformed into SMX in the basic lysate. This reaction 
corresponds to an amide hydrolysis and can be conducted by several enzymes (Figure 
5), such as aryl-acylamidases (EC 3.5.1.13) (Helbling et al., 2010), N-acetyl-
phenylethylamine hydrolases (EC 3.5.1.85) (Larcher and Yargeau, 2011; Pluvinage et 
al., 2007) and arylamine N-acetyltransferases (EC 2.3.1.5) (Larcher and Yargeau, 2011). 
Arylamine N-acetyltransferases are present in archaea (BRENDA The Comprehensive 
Enzyme Information System) and likely need CoA to deacetylate acetyl-SMX. In the 
presence of ATP, NAD+, or NADP+, however, available CoA is likely consumed to 
produce acetyl-CoA (Wolfe, 2015), consistent with the considerably low transformation 
rate of acetyl-SMX observed when these coenzymes were added (Figure S6a). The 
addition of CoA did not have a positive effect on acetyl-SMX transformation (Figure 
S6a), because it was conducted together with ATP in a concentration 10-times lower. 
Beside arylamine N-acetyltransferases, also the action of hydrolases on acetyl-SMX 
would explain the decreased transformation rate upon ATP, NAD+ or NADP+ addition. 
In fact, an inhibitory effect of ATP and NAD+ has already been reported for enzymes 
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belonging to the class EC 3.5.1.- (BRENDA The Comprehensive Enzyme Information 
System).  
Acetaminophen, like acetyl-SMX, is an anilide completely transformed in the basic 
lysate and inhibited in the presence of ATP, NAD+, or NADP+. This was consistent with 
the results obtained for acetyl-SMX and indicates that acetaminophen might as well 
suffer a deacetylation by arylamine N-acetyltransferases or by hydrolases acting on non-
peptide C-N bonds (EC 3.5.1.-). This is also consistent with literature reporting 
deacetylation of acetaminophen as major primary step in the microbial transformation 
pathway of acetaminophen (Wu et al., 2012).  
SMX removal clearly improved when membrane proteins were solubilized with 
detergents (Table 1, Figure 2b). Mohatt et al. (2011) found a cleavage of the isoxazole 
ring of this sulfonamide under iron-reducing conditions. According to Mohatt et al. 
(2011), an abiotic reduction of the N-O bond mediated by microbial reactions that 
reduce Fe(III) to generate Fe(II) can explain this transformation mechanism. More 
specifically, this reaction might depend on ferroxidin, an iron-sulphur protein involved 
in diverse microbial redox systems. Cytochrome c, an abundant protein in membranes 
of acetate-grown cells, and membrane-bound hydrogenases are involved in the 
reduction-oxidation of ferroxidin during aceticlastic methanogenesis and glucose 
catabolism, respectively (Ferry, 2015). Therefore, the higher transformation of SMX in 
the presence of detergents might be related to the recovery of cytochrome c or 
membrane-bound hydrogenases, which could be indirectly involved in the reduction of 
the N-O bond of the isoxazole ring in SMX. 
Membrane proteins could be also related with an increased transformation of terbutryn 
and climbazole (Table 1, Figure 2c). Terbutryn was not transformed into terbutryn-
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sulfoxide, since this TP was not detected in any transformation assay. Therefore, other 
reactions might occur. In anaerobic digestion, the main membrane enzymes involved 
are hydrogenases, methyltransferases and reductases (Ferry, 2015). Taking into account 
the chemical structure of terbutryn, certain S-methyltransferases (EC 2.1.1.-) (Swiss 
Institute of Bioinformatics) present in the cytoplasm and in membranes of 
Methanosarcina sp. (Abram et al., 2011), might be able to perform S-demethylation of 
terbutryn, as occurs with methyl-CoM and other thio-ethers (Richter et al., 2015).  
The case of climbazole is more complex, since its transformation improves with 
detergents (Table 1, Figure 2d), but it is hampered by peptidase inhibitors (Table 3, 
Figure S7b) and by NAD+ (Table 2, Figure S6g). Furthermore, in the presence of NADH 
the ketone group of climbazole can be reduced to an alcohol (Figure S6g-h and Figure 
5) which was confirmed by the detection and quantification of the TP climbazole-
alcohol. According to Brienza and Chiron (2017), this reaction could be catalysed by a 
carbonyl reductase (probably EC 1.1.1.184) in a reversible way, which supports our 
findings. However, the non-detection of the TP climbazole-alcohol in the basic lysate 
indicates that climbazole can be transformed also by other enzymatic reactions not 
identified so far.  
Diclofenac is quite persistent under anaerobic conditions (Ghattas et al., 2017; 
Gonzalez-Gil et al., 2017), accordingly slight removal efficiencies were observed in the 
present study (only in few cases it achieved significant removal values > 20%, Table 
S5). Decarboxylation reactions (Ghattas et al., 2017) and phosphorylation reactions 
(Gonzalez-Gil et al., 2017) were suggested in previous studies for the anaerobic 
biotransformation of diclofenac. Many decarboxylases (EC 4.1.1.-) participate in 
anaerobic digestion; thus, they could be potential candidate enzymes to catalyse 
decarboxylation of diclofenac (Figure 5). Phosphorylation of the carboxylic group of 
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diclofenac is also likely and might be catalysed by kinases, such as acetate kinases (EC 
2.7.2.1) (Gonzalez-Gil et al., 2017), which transfer a phosphate group from ATP to the 
compound.  
Atenolol is likely transformed into atenolol acid through amide hydrolysis (Figure 5) 
(Krah et al., 2016). Indeed, the formation of atenolol acid in the basic lysate could be 
unambiguously confirmed by QToF measurements in comparison with an authentic 
standard (Table S6 and Table S7). The reaction could be catalysed by amidases and was 
inhibited by AEBSF (Table 3, Figure 4c), a serine protease inhibitor. Actually, it was 
shown that amidases can be inactivated by protease inhibitors (Patterson et al., 1996) 
and that some serine proteases (EC 3.4.21) have amidase and even esterase activities 
(Patel et al., 2012). Besides, protein degradation in bacteria (particularly by serine 
proteases) requires metabolic energy (Fischer and Glockshuber, 1993). As previously 
discussed, the energy production pathway in the basic lysate seems to be hindered when 
ATP, NAD+ and NADP+ were added. Consistently, these cofactors, but not NADH, 
have a negative effect on atenolol biotransformation into atenolol acid (Table 2).  
According to its chemical structure, also bezafibrate could undergo an amide 
hydrolysis (Krah et al., 2016), though the enzymatic activity towards this compound 
was only partially recovered in the presence of NADH (15% removal).  
The biotransformation of clarithromycin, citalopram and erythromycin presented a 
reversible kinetic pattern (e.g., Figure S6e-f and Figure S7c-d); hence, at least two 
reactions are involved hampering the elucidation of their individual action. The removal 
of the three OMPs decreased in the presence of peptidase inhibitors. However, above 
OMPs do not have a peptide bond in their chemical structure (Tables S2). As previously 
pointed out by Krah et al. (2016), it cannot be excluded that the applied inhibitors also 
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affect other non-peptidase activities. Erythromycin as well as clarithromycin could be 
biotransformed by esterases (EC 3.1.-) (Krah et al., 2016, Terzic et al., 2018), or by 
serine proteases with esterase activity (Patel et al., 2012) explaining the negative effect 
of AEBSF inhibitor. Glycosylases (EC 3.2,-) can neither be excluded, since both 
compounds hold a hexose sugar (cladinose) and actually the resulting TPs of this group 
cleavage (Figure 5) were detected in the assays with NAD+ by QToF measurements 
(Table S6 and Table S7) and they were recently identified as major TPs in activated 
sludge cultures (Terzic et al., 2018). In addition, the three OMPs all comprise a tertiary 
amine that could undergo a N-demethylation as shown for clarithromycin and 
erythromycin in activated sludge systems (Terzic et al., 2018). However, we could not 
prove the formation of the corresponding TPs. Citalopram transformation might depend 
on enzymes directly or indirectly involved in ATP synthesis (as previously discussed 
for atenolol), since the addition of the coenzymes ATP, NAD+ and NADP+ inhibited it, 
while NADH did not (Table 2). However, considering the available data we cannot 
identify the specific enzymes.  
Anaerobic O-demethylation is a very common process in anaerobic environments and 
has already been observed for tramadol, trimethoprim and venlafaxine (Falås et al., 
2016; Ghattas et al., 2017; Rühmland et al., 2015). Although the biotransformation of 
these OMPs was not achieved in the lysate conditions tested, some O-demethylated TPs 
of trimethoprim and tramadol, but not of venlafaxine, were detected in the anaerobic 
sludge experiments (Figure S4c,d). These reactions could be catalysed by 
methyltransferases (EC 2.1.1.-) (Figure 5) present in anaerobic bacteria (Studenik et al., 
2012). However, these enzymes might have not been recovered in the lysates.  
Finally, although the anaerobic transformation of the different OH-CBZ OMPs (10-
OH-CBZ, 10,11-DiOH-CBZ, 2-OH-CBZ and 3-OH-CBZ), acesulfame, acyclovir and 
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iopamidol is very unlikely (Figure 1), their removal in other biological systems could 
depend on oxidoreductases (EC 1.-), since they were only transformed when oxidizing 
or reducing cofactors (Table 2) were added to the basic lysate. This points out that the 
transformation pathways promoted with the addition of cofactors might be usually 
hindered in anaerobic systems. According to Castronovo et al. (2017) acesulfame is 
degraded under oxic and anoxic conditions, but not under anaerobic conditions. Hence, 
only when reducing conditions of anaerobic digestion were switched to by adding 
NAD+, acesulfame was transformed. Acyclovir was transformed in the presence of 
NADP+, but no considerable increase of the TP carboxy-acyclovir was detected, as did 
happen with bead beating lysate (Figure S5b), suggesting that different enzymatic 
pathways might be involved. Iopamidol was also transformed when NADP+ was 
supplied. Under aerobic conditions the primary alcohols of this contrast media are 
oxidised to carboxylic acid by many different types of enzymes, including NAD(P)-
dependent alcohol dehydrogenases (Kormos et al., 2010). In contrast, the different OH-
CBZ were transformed when the reducing coenzyme NADH was supplied. The 
transformation pathway of 10-OH-CBZ and 10,11-DiOH-CBZ under aerobic conditions 
is initiated by oxidation of the hydroxyl groups to ketones and the formation of 9-
carboxy-acridine and acridone was reported (Kaiser et al., 2014). As expected, the 
formation of these TPs were not detected in the presence of the reducing cofactor NADH 
and this suggests a different transformation pathway with NADH-dependent enzymes 
being involved. 2-OH-CBZ and 3-OH-CBZ might follow a wide variety of 
oxidoreductive reactions, but amide hydrolysis, o-methylation, dimerization and other 




Figure 5. Possible enzymatic biotransformation mechanisms of selected OMPs. The 
predicted TPs that were detected in the present study are marked with a tick. The 
enzymatic categories correspond to arylamine N-acetyltransferases (EC 2.3.1.5), N-
acetyl-phenylethylamine hydrolases (EC 3.5.1.85), aryl-acylamidases (EC 3.5.1.13), 
glycosylases (EC 3.2.-), carbonyl reductases (EC 1.1.1.184), serine proteases (EC 
3.4.21.-), O-methyltransferases (EC 2.1.1.-), decarboxylases (EC 4.1.1.-) and acetate 




Table 4. Summary of certain reactions and enzymes likely involved in the anaerobic biotransformation of OMPs. Enzymes in italics present a 
higher degree of uncertainty because no TPs were identified. The enzymatic reactions observed for OH-CBZs, acesulfame, acyclovir and iopamidol 
are not included since they are not expected to occur in anaerobic systems. 
OMP TP detected Reaction  Candidate enzymes or enzymatic classes References 
Acetyl-SMX 
 
SMX Deacetylation/hydrolysis of 
secondary amide 
Arylamine N-acetyltransferase (EC 2.3.1.5) 
Aryl-acylamidase (EC 3.5.1.13) 
Acetyl-phenylethylamine hydrolase (EC 3.5.1.85) 
Helbling et al. (2010) 
Larcher and Yargeau (2011) 




Arylamine N-acetyltransferase (EC 2.3.1.5) 
Hydrolases of non-peptide C-N bonds (EC 3.5.1.-) 
Wu et al. (2012) 
Atenolol Atenolol acid Primary amide hydrolysis Serine proteases (EC 3.4.21) Krah et al. (2016) 
Clarithromycin 
Erythromycin 
Clarithromycin TP 590 
Erythromycin TP 576 
Cleavage of cladinose  
Ester hydrolysis of macrolid 
group 
Demethylation of tertiary 
amine 
Glycosylases (EC 3.2,-) 
Esterases (EC 3.1.-) 
Serine proteases (EC 3.4.21) 
Unknown 
Krah et al. (2016) 
Terzic et al. (2018) 
Patel et al. (2012) 
Terzic et al. (2018) 
Climbazole Climbazole-alcohol Ketone reduction Carbonyl reductase (EC 1.1.1.184) Brienza and Chiron (2017) 
Citalopram  






Acetate kinase (EC 2.7.2.1) 
Decarboxylases (EC 4.1.1.-) 
Gonzalez-Gil et al. (2017) 
Ghattas et al. (2017) 
SMX  Reduction of N-O bond in 
isoxazole ring 
Membrane proteins as: 
Ferredoxin hydrogenase (EC 1.12.7.2) 
Cytochrome c 
Mohatt et al. (2011); Ferry 
(2015) 
Terbutryn  S-methyl group Membrane S-methyltransferases (EC 2.1.1.-) 
Richter et al. (2015); Abram 





O-demethylation O-methyltransferases (EC 2.1.1.-) Ghattas et al. (2017); 
Rühmland et al. (2015) 
Venlafaxine  O-demethylation O-methyltransferases (EC 2.1.1.-) 
Falås et al. (2016); 
Rühmland et al. (2015) 
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4. Conclusions 
The extraction of native sludge enzymes, together with the use of detergents, cofactors, 
and inhibitors, provides key information to understand the biotransformation of a variety 
of OMPs. It was demonstrated that most of the OMPs that were significantly 
biotransformed (>20%) in anaerobic sludge undergo enzymatic reactions, namely 
acetyl-SMX, acetaminophen, clarithromycin, erythromycin, citalopram, climbazole, 
atenolol, terbutryn, and SMX. 
The huge number of enzymes that could participate in a biological process, the 
interdependency of their activities, and the complexity of OMPs, which usually have 
several functional groups susceptible to be transformed, make it difficult to elucidate 
the enzymatic pathways involved in OMP biotransformation. In this first approach, we 
found some links between the enzymatic activities and the transformation of OMPs 
combining the knowledge about anaerobic enzymatic pathways and OMP reactivity. 
However, further research focusing on identifying proposed TPs and performing 
metaproteomic analysis is needed to corroborate these hypotheses, to identify more 
responsible enzymes and to confirm the enzymatic reactions of OMPs in the basic 
lysates also occurring in anaerobic digesters. 
Overall, this study aims to be a starting point for elucidating the responsible enzymes of 
OMP biotransformation under anaerobic conditions. However, there are still many 
pieces in the OMP biotransformation puzzle that need to be assembled to gain a clearer 
overview of this process. 
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